Skip to content

Intestinal microecology study for probiotics in children with asthma

Intestinal microecology study for probiotics in children with asthma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019832
Enrollment
Unknown
Registered
2018-12-02
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

Group 1:Routine treatment with probiotics intervention
Group 2:Routine treatment without probiotics intervention

Sponsors

Qilu Children's Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 14 Years

Inclusion criteria

Inclusion criteria: (1) Children with asthma admitted to the respiratory department of Qilu Children's Hospital, the clinical diagnostic criteria refer to the 2016 edition of the Guide for Diagnosis and Prevention of Childhood Bronchial Asthma; (2) 3-14 year old children with asthma who are included in the Jinan and surrounding areas of Dezhou, Liaocheng, Jining, Heze, Zibo, Tai'an and Laiwu; (3) sudden onset of wheezing, cough, shortness of breath, chest tightness, etc., or the original symptoms sharply aggravated; (4) There is no systemic use of antibiotics, antifungal drugs, hormones, etc. that affect the oral micro-ecological status within one month; (5) There is no oral topical medication within one month: hormones, antibiotics, etc.

Exclusion criteria

Exclusion criteria: (1) Have suffered from severe cardiovascular system, digestive system, respiratory system, urinary system and other organ dysfunction or insufficiency during past or enrollment; (2) The recent application of adrenocortical hormone or immunomodulatory drugs for less than 3 months; (3) Combined with systemic infection at the time of enrollment; (4) can not tolerate atomization treatment; (5) Child patients who have used antibiotics within half a year.

Design outcomes

Primary

MeasureTime frame
16S rDNA;

Countries

China

Contacts

Public ContactLiu Jian

Shandong tanke Biotechnology Co., Ltd.

tankelj@126.com+86 0531-88755508

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026